Association of risk factors and bleeding complications in Asian patients taking edoxaban

Trial (n=346) found weight ≤60 kg & presence of cancers could affect bleeding complications, which occurred despite proper edoxaban treatment in Asian patients. Authors suggest possibility of using more strict dosage guideline could be considered in patients of Asian ethnicities.

Source:

British Journal of Clinical Pharmacology